Back to top
more

Virtus LifeSci Biotech Clinical Trials ETF: (BBC)

(Delayed Data from NYSE) As of Oct 27, 2025 03:59 PM ET

$31.72 USD

31.72
23,485

+1.15 (3.77%)

Volume: 23,485

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $31.94 +0.22 (0.69 %) 7:58 PM ET

Zacks News

Sweta Killa headshot

Biotech Leading in Q4: Best ETFs & Stocks

We highlight five biotech ETFs and stocks that are leading the market in Q4.

Sanghamitra Saha headshot

Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

Sweta Killa headshot

5 Market-Beating Sector ETFs of 2019

Braving all hurdles including recession fears, trade dispute, Brexit and geopolitical tensions, Wall Street has enjoyed a huge rally this year with all the three major indices hitting record highs lately.

Sanghamitra Saha headshot

5 ETF Areas Up At Least 45% in 2019

These ETF areas crushed the S&P 500 in 2019.

Neena Mishra headshot

Top Performing ETFs of 2019

We take a look at the best performing areas of the market

Sweta Killa headshot

5 Best-Performing ETFs of Last Week

Wall Street continued its uptrend last week with the S&P 500 and Nasdaq hitting new highs, climbing 0.7% and 0.9%, respectively.

Sanghamitra Saha headshot

Beyond Biotech, 5 ETFs Up At Least 10% in Q4

Apart from biotech, these ETFs are seeing solid momentum in the ongoing quarter.

Neena Mishra headshot

Why Biotech ETFs are Surging to New Highs

increasing M&A deals and cutting edge therapies are driving biotech ETFs higher

Sweta Killa headshot

Biotech ETFs Hit New Highs on Deal Activities

Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Sweta Killa headshot

Biotech ETF (BBC) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

Sanghamitra Saha headshot

Top ETF Stories of November

Inside the key ETF events of the month of November.

Sweta Killa headshot

Top & Flop ETFs of November

November was kind to the stock market with major bourses logging the best monthly gain since June.

Sweta Killa headshot

Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

Sanghamitra Saha headshot

Top and Flop ETFs of Last Week

Last week was downbeat for the broader market owing to uncertainty over the signing of the ???phase-one??? trade deal between the United States and China.

Sweta Killa headshot

Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

Healthcare bounced back with an outperformance starting the fourth quarter.

Sweta Killa headshot

S&P 500 at Record High: 6 ETF Winners of Last Week

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.

Sweta Killa headshot

Healthcare ETFs Win in October: Here's Why

The healthcare sector, which has been the second-worst performer among the 11 major S&P 500 sectors this year, took the center stage this month with some outperformance compared to other sectors.

Sweta Killa headshot

Biotech ETFs Surge on a Flurry of Positive News

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.

Sweta Killa headshot

Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

Sanghamitra Saha headshot

6 Wining ETF Areas From a Late Santa Rally

These sector ETFs have made the most of the start of this Santa Rally.

Sanghamitra Saha headshot

4 Worst ETF Areas of Q4

These ETF areas have been particularly painful in the bloodbath of the fourth quarter.

Sweta Killa headshot

Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?

Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.

Sweta Killa headshot

Top and Flop ETFs at Half-Way Q4

We have highlighted both the best and worst performing zones and their ETFs at halfway Q4.

Sanghamitra Saha headshot

ETF Areas That Spooked Investors in October

These ETF areas lost the most in the Halloween month and gave investors the chills.

Sanghamitra Saha headshot

Scared of a September Lull? Play 6 ETFs

These ETFs may perform well in ill-famed September due to solid fundamentals.